Cargando…

Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues

Glucagon like peptide (GLP-1) analogues are a relatively novel medication developed primarily for the treatment of type 2 diabetes since 2005. Although GLP-1 analogues have been shown to be more effective in the first few years of diagnosis in type 2 diabetes, we report a case of a patient with long...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raja, Umar Y, Eastaugh, Alison E, Younas, Mohammed S, Hanif, Wasim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359167/ https://www.ncbi.nlm.nih.gov/pubmed/26668738 http://dx.doi.org/10.1177/2048004015576008

Ejemplares similares

Counselling Patients for GLP-1 Analogue Therapy: Comparing GLP-1 Analogue with Insulin Counselling
por: Kalra, Sanjay, et al.
Publicado: (2012)

Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L
por: Blonde, Lawrence, et al.
Publicado: (2020)

The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour
por: de Boer, Stefanie Amarens, et al.
Publicado: (2015)

GLP-1 Analogue Liraglutide Attenuates Mutant Huntingtin-Induced Neurotoxicity by Restoration of Neuronal Insulin Signaling
por: Chang, Ching-Chi, et al.
Publicado: (2018)

Effects of Teraphy with Basal Insulin Analogues Combined with GLP 1 Analogues and Metformin in the Treatment of Obese Patients with Poorly Regulated Postprandial Glycemia
por: Buturovic, Belma Ascic, et al.
Publicado: (2014)

The role of GLP-1 mimetics and basal insulin analogues in type 2 diabetes mellitus: guidance from studies of liraglutide
por: Barnett, A H
Publicado: (2012)

Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
por: Valla, Vasiliki
Publicado: (2010)

Cardioprotective role of insulin: Advantage analogues
por: Maiti, Rituparna, et al.
Publicado: (2012)

GLP-1 and hunger modulate incentive motivation depending on insulin sensitivity in humans
por: Hanssen, Ruth, et al.
Publicado: (2021)

Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans
por: Heni, Martin, et al.
Publicado: (2015)

Prolonged control of insulin-dependent diabetes via intramuscular expression of plasmid-encoded single-strand insulin analogue
por: Deng, Lu, et al.
Publicado: (2022)

Engineering of Insulin Receptor Isoform-Selective Insulin Analogues
por: Glendorf, Tine, et al.
Publicado: (2011)

Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
por: Bajaj, Harpreet S, et al.
Publicado: (2023)

Review of Insulin and its Analogues in Diabetes Mellitus
por: Mane, Krishnappa, et al.
Publicado: (2012)

Insulin Degludec Aspart: The First Co-formulation of Insulin Analogues
por: Kalra, Sanjay
Publicado: (2014)

Basal Insulin Use With GLP-1 Receptor Agonists
por: Anderson, Sarah L., et al.
Publicado: (2016)

Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes
por: Salehi, Marzieh, et al.
Publicado: (2010)

Upregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretion
por: Ahlkvist, L, et al.
Publicado: (2013)

Insulin and GLP-1 infusions demonstrate the onset of adipose-specific insulin resistance in a large fasting mammal: potential glucogenic role for GLP-1
por: Viscarra, Jose A, et al.
Publicado: (2013)

Chymotrypsin substrate analogues inhibit endocytosis of insulin and insulin receptors in adipocytes
Publicado: (1986)

Production costs and potential prices for biosimilars of human insulin and insulin analogues
por: Gotham, Dzintars, et al.
Publicado: (2018)

Human Insulin Versus Insulin Analogues: A True Companion Forgotten
por: Abdi, Hengameh
Publicado: (2019)

The effects of GLP-1 analogues on pre-diabetes of the children
por: Zhou, Qing-Xia, et al.
Publicado: (2017)

Safety and Efficacy of Modern Insulin Analogues
por: Yoo, Hye Jin, et al.
Publicado: (2013)

Immunologic Tolerance to the Insulin Analogue Glulisine
por: Ozaki, Nobuaki, et al.
Publicado: (2010)

The GLP-1 Analogue Exenatide Improves Hepatic and Muscle Insulin Sensitivity in Diabetic Rats: Tracer Studies in the Basal State and during Hyperinsulinemic-Euglycemic Clamp
por: Wu, Hui, et al.
Publicado: (2014)

Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
por: Moreira, Rodrigo Oliveira, et al.
Publicado: (2018)

Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes
por: Heller, Simon, et al.
Publicado: (2023)

Differential Stimulation of Insulin Secretion by GLP-1 and Kisspeptin-10
por: Schwetz, Tara A., et al.
Publicado: (2014)

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
por: Hemkens, L. G., et al.
Publicado: (2009)

Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
por: Mannucci, Edoardo, et al.
Publicado: (2010)

The local GLP-1 system in the olfactory bulb is required for odor-evoked cephalic phase of insulin release in mice
por: Montaner, Mireia, et al.
Publicado: (2023)

Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
por: Handelsman, Yehuda, et al.
Publicado: (2019)

GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence
por: Meloni, A R, et al.
Publicado: (2013)

Molecular Characterisation of Long-Acting Insulin Analogues in Comparison with Human Insulin, IGF-1 and Insulin X10
por: Hansen, Bo F., et al.
Publicado: (2012)

Current european regulatory perspectives on insulin analogues
por: Enzmann, Harald G, et al.
Publicado: (2011)

The metabolic and mitogenic properties of basal insulin analogues
por: Tennagels, Norbert, et al.
Publicado: (2013)

Degludec: the new ultra-long insulin analogue
por: Tambascia, Marcos Antonio, et al.
Publicado: (2015)

Characterisation of insulin analogues therapeutically available to patients
por: Adams, Gary G., et al.
Publicado: (2018)

Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
por: Jakobsen, Marie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9g16f8nldmah35s9or42blb011